Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
67
NMPA:67
Drug Approvals
Ambroxol Hydrochloride Granules
- Product Name
- 盐酸氨溴索颗粒
- Approval Number
- 国药准字H20090026
- Approval Date
- Aug 7, 2023
NMPA
Ambroxol Hydrochloride Granules
- Product Name
- 盐酸氨溴索颗粒
- Approval Number
- 国药准字H20123026
- Approval Date
- Aug 7, 2023
NMPA
Tenofovir Alafenamide Fumarate Tablets
- Product Name
- 富马酸丙酚替诺福韦片
- Approval Number
- 国药准字H20233581
- Approval Date
- May 19, 2023
NMPA
Lomefloxacin Aspartate Injection
- Product Name
- 门冬氨酸洛美沙星注射液
- Approval Number
- 国药准字H20063647
- Approval Date
- Aug 4, 2020
NMPA
Buprenorphine Hydrochloride Injection
- Product Name
- 盐酸丁丙诺啡注射液
- Approval Number
- 国药准字H12020275
- Approval Date
- Aug 4, 2020
NMPA
Ramosetron Hydrochloride Injection
- Product Name
- 盐酸雷莫司琼注射液
- Approval Number
- 国药准字H20054781
- Approval Date
- Aug 4, 2020
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- Next
Clinical Trials
No trials found
News
No news found